(Allergan plc)

	AGN latest price $156.3119 (-1.12%) ($155.8876 - $159.1830) on Fri. May. 18, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.02% (three month average)
RSI	56
Latest Price	$156.3119(-1.12%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.7% a day on average for past five trading days.
Weekly Trend	AGN advances 2.1% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(48%)    XBI(46%)    ARKG(45%)    SPY(45%)
Factors Impacting AGN price	AGN will decline at least -1.01% in a week (0% probabilities).   VIXM(-28%)    TLT(-21%)    UUP(-19%)    VXX(-16%)    DIA(-9%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.01% (StdDev 2.02%)
Hourly BBV	0 ()
Intraday Trend	-1%

5 Day Moving Average	$153.7(1.7%)
10 Day Moving Average	$150.09(4.15%)
20 Day Moving Average	$151(3.52%)
To recent high	-5.8%
To recent low	10.7%
Market Cap	$51.536b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed